180
Participants
Start Date
December 31, 2000
Primary Completion Date
June 30, 2003
meloxicam oral suspension
naproxen oral suspension
107.235.23 Arkansas Children's Hospital, Little Rock
107.235.17 Valley Children's Hospital, Madera
107.235.37, San Diego
107.235.4 Boehringer Ingelheim Investigational Site, Denver
107.235.12 Boehringer Ingelheim Investigational Site, Hartford
107.235.13 Alfred I. DuPont Hospital for Children, Wilmington
107.235.36 Arthritis Associates Clinical Research of South Florida, Delray Beach
107.235.21 Miami Children's Hospital, Miami
107.235.38 Clinical Research Dept #7006, Saint Petersberg
107.235.8 Boehringer Ingelheim Investigational Site, Chicago
107.235.7 Boehringer Ingelheim Investigational Site, Kansas City
107.235.25 University of Louisville, Louisville
107.235.16 Children's Hospital - Department of Rheumatology, New Orleans
107.235.26 Deparment of Rheumatology, Boston
107.235.2 E15 Mayo Clinic, Rochester
107.235.18 Washington University School of Medicine, St Louis
107.235.9 Boehringer Ingelheim Investigational Site, St Louis
107.235.31 Department of Pediatrics, Omaha
107.235.35 Arthritis and Rheumatic Disease Center, Livingston
107.235.24 The Children's Hospital of Buffalo, Buffalo
107.235.19 Columbia Presbyterian Medical Center, New York
107.235.22 Oklahoma Medical Research Foundation, Oklahoma City
107.235.33 Healthcare Research Consultants, Tulsa
107.235.32 Arthritis and Osteoporosis Center, Duncansville
107.235.39 Division of Ambulatory Pediatrics, Providence
107.235.10 Texas Scottish Rite Hospital, Dallas
107.235.1 University of Utah School of Medicine, Salt Lake City
107.235.30 Children's Hospital, Seattle
107.235.20 Medical College of Wisconsin, Milwaukee
107.235.61, Cerqueira César
107.235.62, Santa Cecília
107.235.60, São Paulo
107.235.40, México, D.F.
107.235.71 Institute of Children and Adolescents Health, Kharkiv
107.235.70 Children Clinical Hospital No. 1, Kiev
107.235.72 Institute of Pediatrics, Kiev
"107.235.73 2nd Children Specialized Clinical Hospital OHMADIT", Kiev
Lead Sponsor
Boehringer Ingelheim
INDUSTRY